We use cookies to provide you with a better experience. If you continue to use this site, we'll assume you're happy with this. Alternatively, click here to find out how to manage these cookies

hide cookie message
80,259 News Articles

Brain-on-a-chip could cure the sick

Matsushita and Tensor to develop drug-testing technology

Matsushita and Tensor Biosciences have signed a five-year agreement on the joint research and commercialisation of a drug-testing technology which will eventually help develop drugs for psychiatric and neurodegenerative disorders, the two companies announced Tuesday.

Since 1999, the Osaka, Japan-based company has been developing the MED 64 System, a chip-like probe which stimulates and records the electrical activity of brain tissue samples at a multitude of locations in parallel, allowing for the real-time study of activity patterns in living brain tissues, according to a statement issued by the two companies.

Using the MED 64 system, Tensor has been developing its unique brain-on-a-chip drug-discovery technology, which allows automated real-time analysis of electrical activity in the brain, it said.

As part of this agreement, Matsushita will patent Tensor's brain-on-a-chip technology, so that it can develop the MED 64 System further and will license it exclusively back to Tensor for use in the discovery of new drugs, the statement said.


IDG UK Sites

How to use an Apple Watch: Everything you need to know about the Apple Watch

IDG UK Sites

Why Scottish Tablet is better than the iPad mini

IDG UK Sites

How Microsoft's HoloLens AR headset will work without needing a computer or phone

IDG UK Sites

Apple MacBook 1.1 GHz review (Retina, 12-inch, Early 2015): The future of Apple laptops